Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
544 studies found for:    Zidovudine OR Retrovir[TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
21 Completed A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC
Condition: HIV Infections
Intervention: Drug: Zidovudine
22 Completed Comparison of ddI Versus Zidovudine in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Didanosine
23 Withdrawn A Study of Zidovudine in HIV-Infected Patients With Kidney Problems
Conditions: HIV Infections;   Kidney Disease
Intervention: Drug: Zidovudine
24 Completed A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus
Condition: HIV Infections
Intervention: Drug: Zidovudine
25 Completed A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Stavudine;   Drug: Zidovudine
26 Completed A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS
Condition: HIV Infections
Intervention: Drug: Zidovudine
27 Completed A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: Zidovudine
28 Completed A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia
Condition: HIV Infections
Intervention: Drug: Zidovudine
29 Active, not recruiting
Has Results
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
Condition: HIV Infections
Interventions: Drug: Tenofovir DF;   Drug: Zidovudine;   Drug: Stavudine
30 Completed A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine
31 Completed Zidovudine and Lamivudine Given Once Versus Twice Daily
Condition: HIV Infections
Intervention: Drug: Lamivudine/Zidovudine
32 Completed The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: Zidovudine
33 Completed The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine
Condition: HIV Infections
Interventions: Drug: Delavirdine mesylate;   Drug: Zidovudine
34 Completed The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System
Condition: HIV Infections
Intervention: Drug: Zidovudine
35 Completed The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)
Conditions: Lymphatic Disease;   HIV Infections
Intervention: Drug: Zidovudine
36 Completed A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women
Condition: HIV Infections
Intervention: Drug: Zidovudine
37 Completed An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
Conditions: AIDS Dementia Complex;   HIV Infections
Intervention: Drug: Zidovudine
38 Completed The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient
Condition: HIV Infections
Interventions: Drug: Oxazepam;   Drug: Zidovudine
39 Completed Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine
40 Completed A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV
Condition: HIV Infections
Interventions: Drug: Glycovir;   Drug: Zidovudine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.